Haas, Maximilian and Burger, Maximilian and Schnabel, Marco J. (2021) Systemic treatment of bladder cancer. UROLOGE, 60 (9). pp. 1167-1174. ISSN 0340-2592, 1433-0563
Full text not available from this repository. (Request a copy)Abstract
Cisplatin-based chemotherapy regimens represent the standard of care in patients with locally advanced or metastatic urothelial carcinoma of the bladder. However, many patients are ineligible for cisplatin due to comorbidities or performance status. Immunotherapy with checkpoint inhibitors (CPI) has become a well-established treatment alternative in metastatic bladder cancer. The following review discusses current literature and guideline recommendations based on two case studies, in order to provide practical know-how about therapy sequences and treatment processes.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | TRANSITIONAL-CELL-CARCINOMA; PHASE-III TRIAL; CISPLATIN-BASED CHEMOTHERAPY; ADVANCED UROTHELIAL CANCER; RANDOMIZED-TRIAL; SUPPORTIVE CARE; TRANSURETHRAL RESECTION; PHOTODYNAMIC DIAGNOSIS; RADICAL CYSTECTOMY; VINFLUNINE PLUS; Polychemotherapy; Immune checkpoint inhibitors; Neoplasm metastasis; Resektion; transurethral; Programmed cell death ligand 1 |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Urologie |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 22 Aug 2022 07:35 |
| Last Modified: | 22 Aug 2022 07:35 |
| URI: | https://pred.uni-regensburg.de/id/eprint/46285 |
Actions (login required)
 |
View Item |
